Zobrazeno 1 - 5
of 5
pro vyhledávání: '"P. Srinivasbabu"'
Autor:
Ragam Swetha Samrajyam, P. Srinivasbabu, Pydala Sai Prasanna, Satheesh S. Gottipati, Ambati Sujatha, Kasani Chitti Ramya
Publikováno v:
International Journal of Advanced Research. 9:128-131
We look at the clinical development of remdesivir, a prodrug that has been shown to inhibit SARS-CoV-2 replication, indicating that it could be used to treat COVID-19. Remdesivir is a nucleotide analogue prodrug that disrupts viral replication and wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a1c286fbe1549f6cf00ea7a0c71c1bf
https://doi.org/10.21474/ijar01/13385
https://doi.org/10.21474/ijar01/13385
Autor:
Dindi Sandhya Rani, Chinta Indu Radha, Anumolu Sai Sivani, Satheesh S. Gottipati and P. Srinivasbabu
In vitro, ivermectin, an anti-parasitic drug licenced by the US Food and Drug Administration, was found to limit the replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).The three groups had similar clinical symptoms of fev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::267650984c98abf955918f9bf3748d53
Autor:
Pydala Sai Prasanna , Ragam Swetha Samrajyam , Kasani Chitti Ramya, Ambati Sujatha , Satheesh S. Gottipati and P. Srinivasbabu
We look at the clinical development of remdesivir, a prodrug that has been shown to inhibit SARS-CoV-2 replication, indicating that it could be used to treat COVID-19. Remdesivir is a nucleotide analogue prodrug that disrupts viral replication and wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50859a5d983a88c7041ac37e5a12afae
Autor:
Vajrala Supriya, Dindi Sandhya Rani, Anumolu Sai Sivani, P. Srinivasbabu, Satheesh S. Gottipati, Chinta Indu Radha
Publikováno v:
International Journal of Advanced Research. 9:701-702
In vitro, ivermectin, an anti-parasitic drug licenced by the US Food and Drug Administration, was found to limit the replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).The three groups had similar clinical symptoms of fev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73470b614e21387a743f55aa51915136
https://doi.org/10.21474/ijar01/13597
https://doi.org/10.21474/ijar01/13597
Publikováno v:
International Journal of Research in Pharmacy and Chemistry. 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1a9487f1a586a5204eb5a54f34e0d4b
https://doi.org/10.33289/ijrpc.10.1.2020.10(23)
https://doi.org/10.33289/ijrpc.10.1.2020.10(23)